More than two dozen state prosecutors are asking the Food and Drug Administration to reconsider its approval of a powerful new painkiller called Zohydro, saying that the narcotic pill could add to the national epidemic of prescription drug abuse.
The new facility, which is estimated to cost nearly €40 million, will be used, among other...
Exercise might help women beat breast cancer. A study finds it can ease the achy joints and...
GREER® Labs has announced that the Allergenic Products Advisory Committee (APAC) of the...
In-Sight® Explorer 4.9 software offers an expanded set of inspection tools and an enhanced Cognex Connect™ communications suite featuring the iQ Sensor Solution network (iQSS). This latest version of In-Sight Explorer software includes the surface flaw tool and the scene correction filter.
The FDA reviews advertising and promotional labels for prescription drugs to make sure the content isn't false or misleading. What materials are regulated? How can advertising violate the law? And what are the consequences? FDA Drug Info Rounds pharmacists discuss the many elements surrounding the marketing and advertising of a drug product.
New version of the eBob software is designed to help users gather real-time inventory data from storage bins. The eBob program works in conjunction with the company’s SmartBob remote level sensors to provide measurement data to personal computers.
The federal health-care law is becoming a heavier political burden for President Obama, despite increased confidence on the economy and the public’s own generally upbeat sense of well-being.
Quintiles has announced the appointment of W. Scott Evangelista to serve as president, Integrated Commercial Services and Solutions. In this role, Evangelista is responsible for leading Quintiles’ global Commercial organization and the ongoing development and delivery of its related service offerings.
Global efforts to curb malaria are stalling after a drop in funds to buy bed nets, according to the latest report Wednesday from the World Health Organization. For the second year in a row, WHO noted a dramatic decline in the number of bed nets given out to protect people from the mosquitoes that spread malaria.
Tens of thousands of women each year might be able to skip at least some of the grueling treatments for breast cancer — which can include surgery, heavy chemo and radiation — without greatly harming their odds of survival, new research suggests.
The slow rollout of a new federal health insurance marketplace may be deepening differences in health coverage among Americans, with residents in some states gaining insurance at a far greater rate than others. The demarcation may be as simple as Democrat and Republican.
British Prime Minister David Cameron says he hopes to kick-start an international effort to find a cure or effective treatment for dementia by 2025. At a one-day summit on dementia on Wednesday hosted by the U.K., Cameron declared that discovering a cure or treatment for dementia is "within our grasp."
Four and five layer composite mesh filters provide extremely high efficiency filtration in both gas and liquid applications. The composite meshes are produced as self-supporting cylinders that, when incorporated into dedicated filtration systems, enable routine filtration down to sub-micron levels.
The MCD-Series Bidirectional Mass Flow and Pressure Controllers precisely and rapidly control mass flow rate, volumetric flow rate and absolute pressure of gases in two flow directions.
The HPR-MicroTM Reactor is ideal for early, exploratory research. It is especially well suited for research, process development, and screening applications when reagents, catalysts, or other essential materials are expensive or available in very limited supply.
Emergent BioSolutions has entered into a definitive agreement with Cangene Corporation under which Emergent will acquire all of the outstanding common shares of Cangene in an all-cash transaction valued at $3.24 per share on a fully diluted basis for an aggregate purchase price of $222 million.
AstraZeneca and Bristol-Myers Squibb Company announced that the FDA's Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) recommends the investigational medicine metreleptin for the treatment of pediatric and adult patients with generalized lipodystrophy (LD).
ScinoPharm today announced that the company has completed construction of its Changshu plant on a 16-acre site. The facilities, located in Changshu, (Jiangsu province) China, include an R&D process development center and a multipurpose API (active pharmaceutical ingredients) manufacturing plant fully compliant with U.S., EU, and Chinese CGMP standards.